Open access peer-reviewed chapter

Pharmacological Potentials of Ginger

Written By

Fatai Oladunni Balogun, Esther Tayo AdeyeOluwa and Anofi Omotayo Tom Ashafa

Submitted: June 19th, 2019 Reviewed: July 26th, 2019 Published: September 30th, 2019

DOI: 10.5772/intechopen.88848

Chapter metrics overview

1,008 Chapter Downloads

View Full Metrics


Zingiber officinale, belonging to the family Zingiberaceae, is a popular spice and herb used as delicacy and to manage numerous diseases such as diabetes, hypertension, cancer, ulcer, diarrhea, cold, cough, spasm, vomiting, etc. in folk medicine from China, India, and Arabia Peninsula to other continents of the world including Africa (Nigeria, Egypt, and so on). Though this review is aimed at summarizing the pharmacological potentials of this well-endowed spice, interestingly, we found out that these reported ethnobotanical uses are attributed to a number of inherent chemical constituents including gingerol, 6-, 8-, 10-gingerol, 6-shogaol, 6-hydroshogaol, oleoresin, etc., eliciting various pharmacological effects, not limited to antioxidant, antitumor/anticancer, anti-inflammatory, antihyperglycemic, antihypertensive, anticholesterolemic, antibiotic/antimicrobial, neuroprotective, antiulcer/gastroprotective, antiemetic, hepatoprotective, and antiplatelet aggregation, safety profiles established through a number of studies (in vitro, in vivo, and cell lines), though some of these potentials are yet to be explored. Sadly, even few of these established effects are yet to be experimented in clinical trials, and only until these are intensified would there be prospect toward drug development for preventive and curative treatments. In conclusion, we are able to highlight and sum up the therapeutic implications of ginger and its related derivatives in the management of ailments confronting humanity.


  • ginger
  • spice
  • pharmacological potentials
  • gingerol
  • 6-
  • 8-
  • 10-gingerol
  • 6-shogaol
  • 6-hydroshogaol
  • oleoresin

1. Introduction

Ginger (Zingiber officinaleRoscoe) is a well-known herbal spice believed to have originated from either India [1] or Southeast Asia [2]. It is a sterile plant, thus reproduced by rhizomes, not by seeds [3], and grows well in tropical and subtropical regions of the world [4]. It is used for culinary purposes, as a seasoning or condiment and as a therapeutic agent [5]. It is known to be an effective spasmolytic, antipyretic, antiemetic, antioxidant, antiulcer, analgesic, hypotensive, antidiabetic, and anti-inflammatory agent [6, 7] containing scented essential oils and spicy oleoresins [8]. Ginger has long been in use therapeutically and currently still validated as a potent medicinal spice for the treatment of various ailments. Indigenously, it has been used against colds [9], sore throats [10], and Staphylococcus aureus[11] and tested effectively against cancer cells [12]. Ginger can be used as a dietary supplement and as additives in the production of various snacks and merchantable products [13]. Additionally, it is considered a safe herbal drug [14], as the spices have been categorized to be generally regarded as safe: “GRAS.”


2. Botanical description, occurrence, and distribution

Zingiber officinale(Roscoe), ginger of the family Zingiberaceae, is an herbaceous (available as rhizomes) perennial plant growing as tall as 90 cm. The leaves, lanceolate, appear to be simple, alternate, distichous, narrow, long possessing sheathing bases with 2–3 cm broad, while the rhizomes (7–15 cm long and 1–1.5 cm broad) are aromatic, thick lobed with pale yellow coloration. The flowers are small, have calyx that are lofty, have sepals very united, are three toothed, and split open on a side with three subequal corolla forming an oblong to lanceolate connate segment with green coloration [15, 16]. Ginger give rise to numerous lateral clump shoot which on maturation appeared dry. Ginger originate from Southeast Asia predominately in India but now well distributed or cultivated in China, Bangladesh, Australia, and Nigeria [17].


3. Ethnobotanical uses

Ginger had been used medicinally since time immemorial with documented use from Sanskrit, Chinese, Greek, Arabic, and Roman ethnomedicine book. However, in the ninth century, Europe recognized the indigenous use of this wonderful spice, and England followed suit in the tenth century. Ginger is used in folkloric medicine for indigestion, high blood pressure, arthritis, intestinal and throat infections, vomiting, nausea, lung diseases, cold, cough, pain, swellings, etc. [15, 17, 18]. Other nutritional uses are found in condiment, beer, wine, and so on [18].


4. Phytochemistry of ginger

Ginger, a spice of diverse health benefits, has been found to be rich in nonnutritive and biologically active compounds known as phytochemicals [19, 20], which have been linked to its health functions. The nutritional and therapeutic values have been recognized in its nutraceutical benefits linked to the presence of certain phytochemicals contained in it. The use of ginger as a nutraceutical agent is not only attributed to its health-augmenting benefits but also to its availability, affordability, and safety.

More than 400 compounds have been found in the chemical analyses of ginger [21]. These compounds includes alkaloids; saponins; flavonoids; steroids; tannins; carbohydrates; glycosides; proteins; amino acids; dietary fiber; ash; phytosterols; vitamins A, B, and C; minerals; and terpenoids [22, 23, 24] while detected to be devoid of acid compounds and reducing sugars [23].

The main components of the ginger rhizome are in the order carbohydrates, lipids, terpenes, and phenolic compounds [25]. The terpenes and the phenolic compounds make up the two foremost classes of phytochemicals in ginger [26]. Phenolic compounds of ginger are also referred to as its nonvolatile components, which have been incriminated in its pharmacological activity. They consist of gingerols and its 6, 8, and 10 derivatives and the corresponding series of homologous shogaol and zingerone, obtained from heat or alkali treated gingerols [26]. Shogaol, paradol, and gingerols have been depicted to be responsible for the pungent taste and smell of ginger [1, 27]. The terpene components of ginger, sesquiterpenes and monoterpenes, are believed to be the volatile fractions [27]. The sesquiterpenes are thought to be a major contributor to the savor of ginger, while the monoterpenes are referred to as the most abundant terpenes in fresh ginger oil [24]. The main sesquiterpenes, zingiberene and β-bisabolene, are responsible for its aromatic scent, while others include α-farnesene, β-sesquiphellandrene, and α-curcumene [21].

Phenolic compounds of ginger are majorly derived from fresh ginger rhizomes, while the terpenes are derived from distillation of ginger oils [26] although their quantity has been found to vary depending on the region of germination. This may be dependent on climate or edaphic conditions as well as genetic variations [28]. The pungent compounds (gingerols, methyl gingerols, shogaols, paradol, and gingerdiones), volatile oil, and other compounds extracted by means of ethanol or acetone constitute the oleoresin [29, 30]. Volatile oils are about 1–4%, lipids about 6–8%, proteins about 9%, and carbohydrates about 50–80% [28] while geraniol is the major essential oil derived in ginger [8].

Zingerone, geraniol, gingerols, shogaols, gingerdiols, gingerdiones, and dehydrogingerdiones have been reported to have antioxidant activity; 6-, 8-, and 10-gingerol and 6-gingerdiol possessed antifungal activity. While 6-gingerol had established antidiabetic and reno-protective activities, zingerone, 6-shogaol, 6-gingerol (anticancer, anti-obesity, and gastroprotective activities), and gingerol and its pungent derivatives (anti-inflammatory activity), 6-shogaol (analgesic, neuroprotective, and strong gastroprotective activities), 6-gingerol, and 6-shogaol, acted against platelet aggregation; 10-gingerol had larvicidal activity; and 6-, 8-, 10-gingerol possessed inotropic activity [24].


5. Pharmacological potentials

The review from most countries of the world such as Egypt [20], Korea [17], Pakistan [15], India [16, 31, 32], Oman [5], Brazil [33], Canada [34] etc. had established the pharmacological potentials of this popular plant, Zingiber officinale(Roscoe), used most times as spice. Additionally, while some reports centers on the action of ginger, others point to the effect of its active components as they target specific diseases including but not limited to diabetes [35], inflammation [25], cancer [22], emetics [36], nausea and vomiting [37] and so on. Thus, the pharmacological potentials (antioxidant, anticancer, antitumor, anti-inflammatory, antihyperglycemic, antihypertensive, anticholesterolemic, antimicrobial, neuroprotective, antiulcer, antiemetic, hepatoprotective) and toxicity profiles of ginger as submitted in these reports are presented one after the other below.

5.1 Antioxidant

The overproduction of free radicals (ROS) in situation where the antioxidant defense mechanism is compromised results into a state of oxidative stress. In order to overcome the excessive free radical (FR) generation and oxidative stress, antioxidants play an important role. Numerous medicinal plants (MPs) and/or their constituents have established their prominence in preventing the onset of diseases particularly those triggered by FR. Ginger, a good example of MPs with excellent antioxidative effect, has been found to exert this action by lowering peroxidation of lipid such as the inhibition of ascorbate/ferrous complex in rat liver microsomes as cited by Rahmani et al. [20] and Mele [17] in the report of Reddy and Lokesh [38] using a concentration of 150 mM (Table 1). Ginger or its derivatives (extracts, compounds, or active components) and gingerol are found to have good scavenging effect against superoxide anion and hydroxyl radicals [63, 64, 65]. In fact, further reports indicated that upon further heating (ginger), this activity remained unaffected [66]. Furthermore, it diminishes the ultraviolet B (UVB)-induced intracellular reactive oxygen species (ROS) and cyclooxygenase (COX)-2 in in vitro and in vivo studies [40]. Other derivatives of ginger such as oleoresin, 6-shogaol, 6-dehydroshogaol, 1-dehydro-6-gingerdione, 6-gingerol, 8-gingerol, 10-gingerol, and essential oil possess pharmacological activities such as antioxidant, antimicrobial, etc., against 2,2-azino-bis-3-ethylbenzothiazoline-6-sulfonic acid (ABTS), 1,1-diphenyl-2-picrylhydrazyl (DPPH), hydroxyl radical, and microbial strains such as Bacillus subtilis, Bacillus cereus, Staphylococcus aureus, Escherichia coli, Candida albicans, Penicilliumspp., and Aspergillus niger[42, 43, 44].

Ginger/derivativesPotentialsAssay(s) employedType of studyConcentration(s) testedExtracts (if any)Country (where the report is published)References
GingerAntioxidantLipid peroxidationIn vivo (rats)150 mMNIIndiaReddy and Lokesh, [38]
Ginger extractsHepatoprotectiveThioacetamide-induced (200 mg/kg i.p)In vivo (rats)250, 500 mg/kgEthanolMalaysiaBardi et al., [39]
Ginger extractsAntiproliferativeHep G2 cellsCell linesNIEthanolMalaysiaBardi et al., [39]
6-gingerolAntioxidant, anti-inflammatoryUVB-induced intracellular reactive oxygen species levelsIn vitro and in vivo (mice)NI (200 μL)AcetoneSouth KoreaKim et al., [40]
GingerAntioxidant, antidiabeticMDA, FRAP streptozotocin-inducedIn vitro and in vivo (rats)5% ginger in daily foodsNIIranAfshari et al., [41]
Oleoresin, 6-gingerol, 8-gingerol, 10-gingerol, 6-shogaol, 6-hydroshogaolAntioxidant, antimicrobial, anti-inflammatoryNitric oxide, ABTS, DPPH, Disc diffusionIn vitroNINIIndia, AlgeriaDugasani et al., [42]; Li et al., [43]; Bellik, [44]
GingerAnticancer (prostrate and liver)0.1% ethionine-inducedIn vitro and in vivo100 mg/kgNIUSA, MalaysiaKarna et al., [45]; Habib et al., [46]
Ginger extractsAnticancer (pancreas)Panc-1 cellsCell lines, in vivoNIEthanolJapanAkimoto et al., [47]
Anti-inflammatory, analgesic, hypoglycemic, safety profileHind pawIn vitro and in vivo50–800 mg/kgEthanolSouth AfricaOjewole, [48]
Ginger oilAntiarthritis, anti-inflammatoryHind pawIn vivo33 mk/kgNIMalaysiaSharma et al., [49]
GingerAntidiabeticStreptozotocin -inducedIn vivo100, 300, 500 mg/kg bwAqueousMalaysiaAbdul Razaq et al., [50]
GingerAntidiabeticStandard spectrophotometric methods (glycation inhibition, glucose diffusion)In vitro5, 10, 20, 40 g/LAqueousPakistanSattar et al., [51]
6-gingerolAntidiabeticStreptozotocin-inducedIn vivo25, 50 mg/kg bwAqueousMalaysiaSukalingam et al., [52]
Ginger, 6-, 8-, and 10-gingerol, while 6-shogaolAntihypertensivePentothal -inducedIn vivo3–10 mg/kgAqueousPakistanGhayur et al., [53]
GingerAnticholesterolemicNIIn vivo50, 500 mg/kgAqueousKuwaitThompson et al., [54]
GingerAntibacterialDisc diffusionIn vitro0.125, 0.25, 0.5, 1.0%
35.25, 75, 250, 500 mg/ml
20, 40, 60, 80, 100 g/ml
Ethanol, ethyl acetate, n-hexane
aqueous, ethanol
aqueous, ethanol
Malu et al., [55]
Ekwenye and Elegalam, [56]
Sebiomo et al., [57]
Oleoresin, essential oilAntifungi and antibacterial (antimicrobial)Disc diffusionIn vitroNI (3 uL)NIAlgeriaBellik, [44]
GingerNeuroprotectiveMonosodium glutamate-inducedIn vivo100 mg/kgAqueousSaudi ArabiaWaggas, [58]
GastroprotectiveHCl-ethanol inducedIn vivo1000 mg/kg
100 mg/kg
AcetoneJapanJohji et al., [59]
6-gingerol, 6-shogaolGastric suppressionHexobarbital inducedIn situ1.75–3.5 mg/kg (i.v), 70–140 mg/kg (oral)NIJapanSuwekawa et al., [60, 61]
GingerHepatoprotectiveCarbon tetrachloride-induced
In vivo
In vivo
100 mg/kg (singly), 50 mg/kg (combination with 100 mg/kg curcumin)
200, 400 mg/kg
Aqueous ethanol
Abdullah et al., 2016
Ajith et al., [62]

Table 1.

Pharmacological potentials of ginger and its derivatives.

NI: Not indicated

5.2 Antitumor/anticancer

Cancer is one of the noncommunicable diseases with great negative impact on global population. It is caused by persistent increase in abnormal human body cells leading to the formation of tumors (of malignant cells) with the possibility to be metastatic [67]. The continuous multiplication of these cells is sometimes associated to influence oxidative stress. A number of treatment (chemotherapy, radiotherapy, synthetic drugs, etc.) are currently available; however, they come with one or several side effects (nausea, hair fall), hence, the need for alternative form of treatment or therapy particularly from MPs. In recent times, quite a number of plant species had found their relevance in the prevention and treatment of cancer, and efforts of researchers to continually develop new moieties are overwhelming. Ginger is a great example of such MPs with excellent prophylactic and curative anticancer properties. Although it must be noted that these effects are not available for all cancer types, several reports on ginger and its derivative (gingerol) have established numerous effects on different types of cancer (lung, colon, ovarian, prostrate, etc.) in a study conducted in the United States by Karna et al. [45] however, daily oral administration of ginger at a concentration of 100 mg/kg body weight (bw) inhibited PC-3 xenograft growth, indicating its effect against prostate cancer in vitro and in vivo. Additionally, the same concentration in another study [46] reduced the increased activity of tumor necrosis factor-alpha (TNF-α) due to the blockage of rat’s liver cancer. Its effect on Panc-1 cells and other cell lines in an in vitro and animal model had been established against cancer of the pancreas, while combining the spice with other spices such as garlic and turmeric provided effectiveness against breast cancer [68]. In line with the aforementioned effects, derivatives of ginger, e.g., 6-shogaol, 8-shogaol, 10-shogaols, 6-gingerol, 6-paradol, and zingerone in several studies had also exhibited activities against different form of cancer including lung, colon, colorectal, ovarian, prostrate as cited by Rahmani et al. [20] and Gunathilake and Rupasinghe [34] from numerous studies. Interestingly, ginger was also reported to hinder tumor growth achieved through different molecular mechanism such as upregulation of suppressor gene, apoptosis, induction, and inactivation of vascular endothelial growth factor (VEGF) (molecular pathways), a tumor angiogenic factor that triggers tumor development and progression [20].

5.3 Anti-inflammatory

Inflammation is a response (defense) felt by the body to dangerous stimuli such as injury to tissues or allergens. However, when these responses are beyond normal, it manifest into arrays of derangements including but not limited to allergies, cancer, autoimmune disorder, metabolic syndrome, and cardiovascular diseases [69]. Interestingly, there are reports of relationship between oxidative stress-triggered FR and inflammation. The use of nonsteroidal anti-inflammatory drugs (NSAIDs) is employed to ameliorate acute and chronic types of inflammation. NSAIDs exhibit this action by inhibiting the enzyme (cyclooxygenase, COX 1 and 2, and/or lipoxygenase, 5, 10, 15) involved in the breakdown of arachidonic acid to prostaglandins. Unfortunately, there are numerous side effects emanating from the use of NSAIDs, hence the search for alternative form of treatment with minimal or no side effects in natural products. Intriguingly, numerous MPs have shown to be effective against inflammatory diseases. Ginger, an example of such MPs including its derivatives, has been reported to possess anti-inflammatory potentials [17] in vitro and in vivo studies [34]. Ojewole [48] submitted the analgesic, anti-inflammatory, hypoglycemic, and safety effect of ginger extract at a dose range of 50–800 mg/kg bw (Table 1). Thirty-three mg/kg bw ginger oil given to rats also alleviated acute and chronic arthritis [49]. Interestingly, ginger exhibits its anti-inflammatory activity in other solvents aside water (used in folkloric medicine), as the reports of Rani et al. [70] corroborate this when ethyl acetate-extracted ginger revealed the best anti-inflammatory effect better than water, methanol (polar solvents), and hexane (nonpolar) against cyclooxygenase and lipoxygenase known as anti-inflammatory enzymes as cited by Gunathilake and Rupasinghe [34] and Mele [17] from various reports. Additionally, ginger plays a very good role in regulating the release of mediators (nitric oxide, prostaglandins), cytokines, TNF, and interleukin (IL)-1, IL-8, via several biochemical pathways attributed to inflammation, etc. [17, 20, 25, 33, 34].

5.4 Antihyperglycemic

Diabetes mellitus (DM) is one of the noncommunicable diseases with major prevalence globally. It is an endocrine disorder or metabolic derangement characterized by hyperglycemia (elevated level of glucose in the blood) due to insufficient or ineffective insulin arising from abnormalities in carbohydrate, lipid, and protein. The treatment or management of DM could be non-pharmacological (exercise, dietary regimen) or pharmacological which entails the use of oral hypoglycemic agents (OHAs) such as sulphonyl ureas, biguanides, and so on. However, the use of these chemicals or synthetic agents is prone to side effects (obesity), unavailability, and unaffordability, hence the dire need for alternative form of treatment with little or no side effects. Surprisingly, these qualities are now found in medicinal plants. In fact, the World Health Organization in a number of their technical reports advocated and encouraged the use of MPs for diabetic control and management. It is interesting to note that quite avalanches of MPs have found their relevance as antidote to curing diabetes [71] and some of its related complications. Ginger is one of such MPs traditionally used to salvage diabetes. In fact, numerous reports are available in the literature [17, 34, 35] establishing the potential of this spice in in vitro and in vivo studies. A similar example is the report of Ojewole [48] as submitted previously in a section (above) of this report. Similarly, 500 mg/kg bw of its aqueous extract lowers plasma sugar level following streptozotocin induction [50] in animal model and in vitro [51]. Since there is a report of correlation between oxidative stress and DM [20] as well as other complications of DM such as hyperlipidemia, hypercholesterolemia, retinopathy, and neuropathy, various publications had revealed the potentials of ginger and its derivatives against these complications as cited by Gunathilake and Rupasinghe [34].

5.5 Antihypertensive

Hypertension, a silent killer (because it shows no symptoms), is characterized by continuous increase in blood pressure in the arteries of a person. It occurs when the systolic and diastolic blood pressures rise above 140/90 mmHg, respectively. Findings revealed excessive salt intake, smoking, alcohol consumption, narrowing of the kidney, and use of birth control pills as some of the causes of hypertension, a risk factor to many cardiovascular diseases (CVD). Like diabetes, the treatment option may be non-pharmacological (lifestyle modification, etc.) or pharmacological involving the use of synthetic moieties such as diuretics, beta blockers (atenolol), angiotensin-converting enzyme inhibitor (Lisinopril), calcium channel blockers, etc. [72]. However, sadly too, all these antihypertensive agents bring about grievous adverse effects such as angioedema, dry cough, weakness, headaches, etc.; thus, there is need for a substitute form of therapy for sufferers of high blood pressure (HBP). Herbal products from MPs have come very handy in the fight geared toward treating HBP, and a notable example of such plant is ginger. In a study involving rats and guinea pigs, extracts of ginger at concentration range of 0.3–3 mg/kg lower the arterial blood pressure of these animals [34]. Additionally, similar study using ginger aqueous extract and its derivatives revealed similar action [53] (Table 1). The activity of ginger as antihypertensive agent was also corroborated in a study [73] involving human subject when twice daily intake of 10 g of the spice reduced the arterial blood pressure to 94.80 mmHg after 2 months. It is worthy of mention that the mechanism of the established action of this spice was through the stimulation of muscarinic receptors and calcium channel blockage.

5.6 Anticholesterolemic

Cholesterol is a constituent of the plasma membranes (eukaryotic) representing sterols [74], needed for growth and development of higher organism. Hypercholesterolemia occurs when there is an elevated level of cholesterol though it suffices to say that there are good (high-density lipoprotein cholesterol (HDL-c)) and bad (low-density lipoprotein cholesterol (LDL-c)) cholesterol. Hypercholesterolemia is a risk factor to many diseases including CVD, atherosclerosis, myocardial infarction (MI), etc. [75] and there are reports of high level of cholesterol in the blood on the influence of excessive production of FRs [76, 77, 78]. The use of herbal medicines or MPs for therapeutic/curative or preventive measures against diseases is an age-long tradition [79]. Ginger is one of such herbal medicine with cholesterol-lowering properties. In a study by Thomson et al. [80] as cited by Gunathilake and Rupasinghe [34], oral administration of 500 mg/kg bw of aqueous extract brought down elevated level of cholesterol in Wistar rats. Another study using mice revealed a 29% reduction in the cholesterol level and other lipid profiles on the administration of 250 μmkg ethanolic extract studied on rabbits [81] and rats (100, 400 mg/kg bw) in a high-fat diet-fed rodents [82]. In the same vein, a study on human subject revealed a positive coadministration of atorvastatin (low dose) and ginger reducing cholesterol level in the blood particularly those subjects suffering from hepatic lesion or inflammation [83].

5.7 Antibiotic/antimicrobial

Infectious diseases are becoming the fastest cause of death globally. A number of bacterial etiological agents cause infections, and the use of antibiotics has become a panacea treatment to the ravishing effects of these microbiological agents. However, it is worthy of mention that the use of antibiotics despite their side effects is in recent times becoming ineffective due to the resistance of these microorganisms which is rapidly increasing [20]. In fact, as a result of these unpalatable trend in the antibiotics use, ongoing efforts have embraced the use of MPs in treating infectious ailments, and a number of plants such as ginger are endowed with established antimicrobial effects as reflected in arrays of in vitro, in vivo, and preclinical studies using different solvents of extraction (ethanol, ethyl acetate, hexane) to inhibit microbial growth as presented by Rahmani et al. [20] and Gunathilake and Rupasinghe [34] from many submissions. Ginger derivatives such as 6-dehydrogingerdione, 6-gingerol, 10-gingerol, and 6-shogaol have established antibacterial effects against strains of bacteria and mycobacterial including Acinetobacter baumannii, Helicobacter pylori, Mycobacterium avium, and M. tuberculosis[17, 20, 34]. Interestingly, to corroborate the effectiveness of ginger and/or its derivatives, a report of potency surpassing common synthetic antibiotics in the fight against infectious diseases is noted [17, 34, 57].

5.8 Neuroprotective

Neuroprotection refers to the way and manner the central nervous system (CNS) is shielded from neuronal damages resulting from acute and/or chronic neurodegenerative disorders (such as stroke, Alzheimer’s, Huntington’s, Parkinson’s diseases) as a consequence of CNS neurons breakdown and/or worsening of the cognitive or intellectual reasoning of the patients [84]. Intriguingly, the emergence of neurodegenerative diseases (NDD) is age-related, i.e., as individual age, so the possibility of suffering from NDD [85]. Medicinal plants such as ginger have continued to find its place in the management and/or treatment of diseases particularly NDD, and these effects are attributed to its inherent phenolic and flavonoid compounds [17, 20]. A root extract of ginger at 100 mg/kg bw extenuates the effect of monosodium glutamate-induced toxicity in rats (Table 1). The emergence or onset of many diseases is triggered by the production of FRs; similarly, since one of the complications of DM is neuropathy, hence, a relationship between FR, NDD, and diabetes is noted. Actually, ginger in separate studies was reported to promote or strengthen the antioxidant defense mechanism of the rat’s brain following streptozotocin induction [86, 87, 88]. Furthermore, 6-shogaol was studied to inhibit microglia in transient global ischemia [89].

5.9 Antiulcer/gastroprotective

Ulcer (gastric or duodenal) is also a disease affecting majority of the populations of the world for more than ten (10) decades now [90], caused by discrepancies between the protective factors (bicarbonates, prostaglandins, mucin, nitric oxide) and aggressive factors (acid and pepsin) leading to a great deal of mortality and morbidity. Several factors [etiologic (Helicobacter pylori) or otherwise, e.g., sedentary lifestyle, diet, drug (NSAIDs), smoking, bacterial infection, free radicals, etc.] influence the emergence and/or progression of ulcer. The treatment involves the use of antimicrobial drugs (metronidazole, tetracycline, amoxicillin, etc.) geared toward eliminating H. pylori, antisecretory agents (omeprazole and so on), antagonist of H2 receptors (cimetidine, ranitidine, etc.), and other agents targeting the disruption of the cell wall or membrane of the bacteria (bismuth salt). However, these series of therapies bring about toxicities, thus the clamor for the alternative form of treatment with little or no toxicities, qualities found in medicinal plants such as ginger. The antiulcerative action of ginger is achieved via the elevation of mucin production [20] and enzyme (thromboxane synthetase) inhibition [17]. A number of studies proving the gastroprotective properties of ginger and some of its constituents such as 6-gingerol and 6-shogaol had been established as compiled or presented in the work of Rahmani et al. [20].

5.10 Antiemetic

Ginger in a study using rodents was found to possess anti-serotonin and 5-HT3 receptor antagonism effect in inducing nausea and vomiting during post-surgery [91]. Derivatives of ginger such as gingerol, shogaols, galanolactone, and diterpenoid were also established to reduce nausea and vomiting [92]. Others revealed that the reports of management of nausea and vomiting in cancer patients are also available in the literature [93].

5.11 Hepatoprotective

The liver is the second largest organ (after the skin) in the body where metabolism of drugs or chemical substance occurs. Hence, important attention is required for this organ for good health status and well-being. Liver ailments also constitute a major health problem in the world today caused sometimes by exposure or ingestion of toxic chemicals (carbon tetrachloride, thioacetamide, certain antibiotics, excessive alcohol intake, etc.), and the use of conventional drugs for the treatment of liver diseases is ineffective and comes with side effects. However, solace has been found with MPs such as ginger as alternative means to treating these ailments. Report of relief from liver cirrhosis following carbon tetrachloride-induced liver toxicity in rats as ginger singly or either in combination with curcumin at 100 mg/kg bw ameliorated the liver injury to the animal [94]. Additionally, ginger in another report at 200, 400 mg/kg bw fortified the activity of antioxidants enzymes (superoxide dismutase, catalase, glutathione peroxidase) while lowering the activity of liver function enzymes (alanine transaminase, aspartate aminotransferase) in the acetaminophen-induced hepatic injury [62] as also corroborated by Rahmani et al. [20] in several studies.

5.12 Toxicity profiles

Toxicity may be acute, subacute, chronic, and subchronic [95]. These studies are carried out to provide information about the safety profile of a substance. Medicinal plants are used as a form of therapeutic measure over a long period against numerous diseases. In fact, despite the fact that the active precursors of a number of chemical moieties or drugs are obtained from plant, the acceptance of herbal medicine and/or formulations are exceedingly growing globally. Intriguingly, 80% of the entire global population are using herbal products for the maintenance of their health due to their perceived thought of originating from nature, lesser side effects, efficacy, safety, affordability, etc., although in some quarters, a very few of these medicinal plants have been reported to cause one form of illness (to the liver and kidney). However, report from several studies has not linked ginger in a way to any of these injuries. This fact is corroborated in reports ascertaining the safety of ginger in different concentrations, 0.5–1.0 g, 2.5 g/kg, 100, 333, 500, 1000, 2000 mg/kg bw, in animal studies for different experimental study period ranging from 10 days, 35 days, 3 months to 2 and half years as nontoxic [20] even during pregnancy (rats) and gynecological operation as revealed by a clinical study [34].

5.13 Other pharmacological activities

The effectiveness of ginger against diseases affecting the eye and other ailments such as osteoarthritis, migraine attack, platelet aggregation, gastrointestinal disturbances, nematode invasion, etc. has been established [15, 17, 18, 20, 34].


6. Conclusion

The world is filled with enormous diseases causing major setbacks to the health status of humanity. Unfortunately, the synthetic moieties adopted for therapeutic and preventive measures are not helping (at all) as they are characterized with side effects. Medicinal plants such as ginger are now being embraced as the alternative options for combating various simple or life-threatening ailments. Since various efforts had established the effectiveness of ginger and its corresponding derivatives on a number of ill-health (though lacking clinical reports), there is much hope in the future that ginger might be able to rescue humankind from these evolving derangements causing setbacks to their living and/or survival.



The authors acknowledge Directorate Research and Development, University of Free State, South Africa, for the Postdoctoral Research Fellowship granted by Dr. FO Balogun tenable in the research group of Phytomedicine and Phytopharmacology at the Department of Plant Sciences, Faculty of Natural and Agricultural Sciences, University of the Free State, Qwaqwa, Free State.


  1. 1. Wakchaure R, Ganguly S. Phytochemistry and pharmacological properties of ginger (Zingiber officinale). In: Mahdi AA, Abid M, Khan AA, Ansair MI, Maheshwari RK, editors. Molecular Biology and Pharmacognosy and Beneficial Plants. Delhi: Lenin Media PVT. LTD.; 2018. pp. 97-103
  2. 2. Park EJ, Pizzuto JM. Botanicals in cancer chemoprevention. Cancer and Metastasis Reviews. 2002;21:231-255
  3. 3. Rout GR, Das P, Goel S, Raina SN. Determination of genetic stability of micropropagated plants of ginger using random amplified polymorphic DNA (RAPD) markers. Botanical Bulletin- Academia Sinica. 1998;39:23-37
  4. 4. Nair KPP. The agronomy and economy of ginger. In: Nair KPP, editor. The Agronomy and Economy of Turmeric and Ginger. Edinburgh, United Kingdom: Elsevier; 2013. pp. 225-292
  5. 5. Ali BH, Blunden G, Tanira MO, Nemmar A. Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinaleRoscoe): A review of recent research. Food and Chemical Toxicology. 2008;46:409-420
  6. 6. Sharma PC, Yelne MB, Dennis TJ. Database on Medicinal Plants used in Ayurveda. New Delhi: Central Council for Research in Ayurveda and Siddha, Department of Indian system of medicine. Govt. of India; 2001; 1: 152 2: 177; 4: 90, 213, 404
  7. 7. Morakinyo AO, Oludare GO, Aderinto OT, Tasdup A. Antioxidant and free radical scavenging activities of aqueous and ethanol extracts ofZingiber officinale. Biologie et Médecine. 2011;3:25-30
  8. 8. Gupta M. Pharmacological properties and traditional therapeutic uses of important Indian spices: A Review. International Journal of Food Properties. 2010;13(5):1092-1116. DOI: 10.1080/10942910902963271
  9. 9. Raal A, Volmer D, Sõukand R, Hratkevitš S, Kalle R. Complementary treatment of the common cold and flu with medicinal plants—results from two samples of pharmacy customers in Estonia. PLoS One. 2013;8:e58642. DOI: 10.1371/journal.pone.0058642
  10. 10. Khayat S, Kheirkhah M, Behboodi Moghadam Z, Fanaei H, Kasaeian A, Javadimehr M. Effect of treatment with ginger on the severity of premenstrual syndrome symptoms. International Scholarly Research Notices: Obstetrics and Gynecology. 2014;2014:79708. DOI: 10.1155/2014/792708
  11. 11. Gull I, Saeed M, Shaukat H, Aslam SM, Samra Z, Athar AM. Inhibitory effect ofAllium sativumandZingiber officinaleextracts on clinically important drug resistant pathogenic bacteria. Annals of Clinical Microbiology and Antimicrobials. 2012;11:8. DOI: 10.1186/1476-0711-11-8
  12. 12. Lee SH, Cekanova M, Baek SJ. Multiple mechanisms are involved in 6-gingerol-induced cell growth arrest and apoptosis in human colorectal cancer cells. Molecular Carcinogenesis. 2008;47:197-208. DOI: 10.1002/mc.20374
  13. 13. Maxwell I. Let’s make ginger beer. Dave’s Garden. 2008
  14. 14. Weidner MS, Sigwart K. Investigation of the teratogenic potential ofZingiber officinaleextract in the rat. Reproductive Toxicology. 2000;15:75-80. DOI: 10.1016/S0890-6238(00)00116-7
  15. 15. Rehman R, Akram M, Akhtar N, Jabeen Q , Saeed T, Shah A, et al.Zingiber officinaleRoscoe (pharmacological activity). Journal of Medicinal Plant Research. 2011;5(3):344-348
  16. 16. Pratap SR, Gangadharappa HV, Mruthunjaya K. Ginger: A potential nutraceutical, an updated review. Journal of Pharmacognosy and Phytochemical Research. 2017;9(9):1227-1238
  17. 17. Mele MA. Bioactive compounds and biological activity of ginger. Journal of Multidisciplinary Science. 2019;1(1):1-7
  18. 18. Gupta SK, Sharma A. Medicinal properties ofZingiber officinaleRoscoe—A Review. IOSR Journal of Pharmacy and Biological Sciences. 2014;9(5):124-129
  19. 19. Sheetal G, Jamuna P. Studies on Indian green leafy vegetables for their antioxidants activity. Plant Foods for Human Nutrition. 2009;64:39-45
  20. 20. Rahmani AH, Shabrmi FM, Aly SM. Active ingredients of ginger as potential candidates in the prevention and treatment of diseases via modulation of biological activities. International Journal of Physiology, Pathophysiology and Pharmacology. 2014;6:125-136
  21. 21. Prasad S, Tyagi AK. Ginger and its constituents: Role in prevention and treatment of gastrointestinal cancer. Gastroenterology Research and Practice. 2015;2015:142979. DOI: 10.1155/2015/142979
  22. 22. Shukla Y, Singh M. Cancer preventive properties of ginger: A brief review. Food and Chemical Toxicology. 2007;45(5):683-690
  23. 23. Ugwoke CEC, Nzekwe U. Phytochemistry and proximate composition of ginger (Zingiber officinale). Journal of Pharmaceutical and Allied Sciences. 2010;7(5). DOI: 10.4314/jophas.v7i5.63462
  24. 24. Dhanik J, Arya N, Nand V. A review onZingiber officinale. Journal of Pharmacognosy and Phytochemistry. 2017;6(3):174-184
  25. 25. Grzanna R, Lindmark L, Frondoza CG. Ginger—an herbal medicinal product with broad anti-inflammatory actions. Journal of Medicinal Food. 2005;8(2):125-132
  26. 26. Ashraf K, Sultan S, Shah SAA. Phytochemistry, phytochemical, pharmacological and molecular study ofZingiber officinaleRoscoe: A review. International Journal of Pharmacy and Pharmaceutical Sciences. 2017;9(11):8-16. DOI: 10.22159/ijpps.2017v9i11.19613
  27. 27. Butt MS, Sultan MT. Ginger and its health claims: Molecular aspects. Critical Reviews in Food Science and Nutrition. 2011;51(5):383-393. DOI: 10.1080/10408391003624848
  28. 28. Ravindran PN. Ginger (Zingiber officinale). In: Jain S, Russel R, editors. Encyclopedia of Herbs and Spices. Vol. 1. Glasgow: Bell and Bain; 2016. pp. 397-409. Available from:
  29. 29. Connell DW. The pungent principles of ginger and their importance in certain ginger products. Food Technology. 1969;21:570-575
  30. 30. Govindarajan VS. Ginger-chemistry, technology, and quality evaluation. Part 1. Critical Reviews in Food Science and Nutrition. 1982;17:1-96
  31. 31. Ahmad B, Rehman MU, Amin I, Arif A, Rasool S, Bhat SA, et al. A review on pharmacological properties of Zingerone (4-(4-Hydroxy-3-methoxyphenyl)-2-butanone). The Scientific World Journal. 2015;2015:816364. DOI: 10.1155/2015/816364
  32. 32. Gupta R, Singh PK, Singh R, Singh RL. Pharmacological activities ofZingiber officinale(ginger) and its active ingredients: a review. International Journal of Scientific and Innovative Research. 2016;4(1):1-18
  33. 33. de Lima RMT, Dos Reis AC, de Menezes APM, Santos JVO, Filho JWGO, Ferreira JRO, et al. Protective and therapeutic potential of ginger (Zingiber officinale) extract and [6]-gingerol in cancer: A comprehensive review. Phytotherapy Research. 2018;32(10):1885-1907. DOI: 10.1002/ptr.6134
  34. 34. Gunathilake KDPP, Vasantha Rupasinghe HP. Recent perspectives on the medicinal potential of ginger. Botanics: Targets and Therapy. 2015;5:55-63
  35. 35. Roufogalis BD.Zingiber officinale(Ginger): A future outlook on its potential in prevention and treatment of diabetes and prediabetic states. New Journal of Science. 2014;2014:674684. DOI: 10.1155/2014/674684
  36. 36. Chaiyakunapruk N, Kitikannakorn N, Nathisuwan S, Leeprakobboon K, Leelasettagool C. The efficacy of ginger for the prevention of postoperative nausea and vomiting: A meta-analysis. American Journal of Obstetrics and Gynecology. 2006;194:95-99
  37. 37. Ali A, Gilani AH. Medicinal value of ginger with focus on its use in nausea and vomiting of pregnancy. International Journal of Food Properties. 2007;10(2):269-278. DOI: 10.1080/10942910601045297
  38. 38. Reddy AA, Lokesh BR. Studies on spice principles as antioxidants in the inhibition of lipid peroxidation of rat liver microsomes. Molecular and Cellular Biochemistry. 1992;111:117-124
  39. 39. Bardi DA, Halabi MF, Abdullah NA, Rouhollahi E, Hajrezaie M, Abdulla MA.In vivoevaluation of ethanolic extract ofZingiber officinalerhizomes for its protective effect against liver cirrhosis. BioMed Research International. 2013;2013:918460. DOI: 10.1155/2013/918460
  40. 40. Kim JK, Kim Y, Na KM, Surh YJ, Kim TY. [6]-Gingerol prevents UVB-induced ROS production and COX-2 expressionin vitroandin vivo. Free Radical Research. 2007;41(5):603-614
  41. 41. Afshari AT, Alireza S, Amirabbas F, Saadatian R, Rasmi Y, Saboory E, et al. The effect of ginger on diabetic nephropathy, plasma antioxidant capacity and lipid peroxidation in rats. Food Chemistry. 2007;101(1):148-153
  42. 42. Dugasani S, Pichika MR, Nadarajah VD, Balijepalli MK, Tandra S, Korlakunta JN. Comparative antioxidant and anti-inflammatory effects of [6]-gingerol, [8]-gingerol, [10]-gingerol and [6]-shogaol. Journal of Ethnopharmacology. 2010;127:515-520
  43. 43. Li F, Wang Y, Parkin KL, Nitteranon V, Liang J, Yang W, et al. Isolation of quinone reductase (QR) inducing agents from ginger rhizome and theirin vitroanti-inflammatory activity. Food Research International. 2011;44:1597-1603
  44. 44. Bellik Y. Total antioxidant activity and antimicrobial potency of the essential oil and oleoresin ofZingiber officinaleRoscoe. Asian Pacific Journal of Tropical Disease. 2014;4:40-44
  45. 45. Karna P, Chagani S, Gundala SR, Rida PC, Asif G, Sharma V, et al. Benefits of whole ginger extract in prostate cancer. The British Journal of Nutrition. 2012;107(4):473-484
  46. 46. Habib SHM, Makpol S, Hamid NAA, Das S, Ngah WZW, Yusof YAM. Ginger extract (Zingiber officinale) has anti-cancer and anti-inflammatory effects on ethionine-induced hepatoma rats. Clinics. 2008;63(6):807-813
  47. 47. Akimoto M, Iizuka M, Kanematsu R, Yoshida M, Takenaga K. Anticancer effect of ginger extract against pancreatic cancer cells mainly through reactive oxygen species-mediated autotic cell death. PLoS One. 2015;10(5):e0126605
  48. 48. Ojewole JA. Analgesic, anti-inflammatory and hypoglycaemic effects of ethanol extract ofZingiber officinale(Roscoe) rhizomes (Zingiberaceae) in mice and rats. Phytotherapy Research. 2006;20(9):764-772
  49. 49. Sharma JN, Srivastava KC, Gan EK. Suppressive effects of eugenol and ginger oil on arthritic rats. Pharmacology. 1994;49(5):314-318
  50. 50. Abdul Razaq NB, Cho MM, Win NN, Zaman R, Rahman MT. Beneficial effects of ginger (Zingiber officinale) on carbohydrate metabolism in streptozotocin-induced diabetic rats. The British Journal of Nutrition. 2012;108(7):1194-1201
  51. 51. Sattar NA, Hussain F, Iqbal T, Sheikh MA. Determination ofin vitroantidiabetic effects ofZingiber officinaleRoscoe. Brazilian Journal of Pharmaceutical Sciences. 2012;48(4):601-607
  52. 52. Sukalingama K, Ganesana K, Ganib SB. Hypoglycemic effect of 6-gingerol, an active principle of ginger in streptozotocin induced diabetic rats. Research and Reviews : Journal of Pharmacology and Toxicological Studies. 2013;96:660-666
  53. 53. Ghayur MN, Anwarul HG, Afridi MB, Houghton PJ. Cardiovascular effects of ginger aqueous extract and its phenolic constituents are mediated through multiple pathways. Vascular Pharmacology. 2005;43(4):234-241
  54. 54. Thompson M, Al-Qattan KK, Al-Sawan SW, Al-Nageeb MA, Khan I, et al. The use of ginger as a potential anti-inflammatory and antithrombotic agent, Prostagladin, leukotriens and essential fatty acids. Prostaglandins, Leukotrienes & Essential Fatty Acids. 2002;67(6):475-478
  55. 55. Malu SP, Obochi GO, Tawo EN, Nyong BE. Antibacterial activity and medicinal properties of ginger (Zingiber officinale). Global Journal of Pure and Applied Sciences. 2008;15(3):365-368
  56. 56. Ekwenye UN, Elegalam NN. Antibacterial activity of ginger (Zingiber officinaleRoscoe) and garlic (Allium sativumL) extracts onEscherichia coliandSalmonella typhi. Journal of Molecular Medicine and Advance Sciences. 2005;1(4):411-416
  57. 57. Sebiomo A, Awofodu AD, Awosanya AO, Awotona FE, Ajayi AJ. Comparative studies of antibacterial effect of some antibiotics and ginger (Zingiber officinale) on two pathogenic bacteria. Journal of Microbiology and Antimicrobials. 2011;3(1):18-22
  58. 58. Waggas AM. Neuroprotective evaluation of extract of ginger (Zingiber officinale) root in monosodium glutamate induced toxicity in different brain areas male albino rats. Pakistan Journal of Biological Sciences. 2009;12(3):201-212
  59. 59. Johji Y, Michihiko M, Rong HQ , Hisashi M, Hajime F. The anti-ulcer effect in rats of ginger constituents. Journal of Ethnopharmacology. 1988;23(2-3):299-304
  60. 60. Suekawa M, Ishige A, Yuasa K, Sudo K, Aburada M, Hosoya E. Pharmacological studies on ginger. I. Pharmacological actions of pungent constituents, (6)-gingerol and (6)-shogaol. Journal of Pharmacobio-Dynamics. 1984;7:13-18
  61. 61. Suekawa M, Ishige A, Yuasa K, Sudo K, Aburada M, Hosoya E. Pharmacological studies on ginger. I. Pharmacological actions of pungent constituents,(6)-gingerol and (6)-shogaol. Journal of Pharmacobio-Dynamics. 1984;7(11):836-848
  62. 62. Ajith TA, Hema U, Aswathy MS.Zingiber officinaleRoscoe prevents acetaminophen-induced acute hepatotoxicity by enhancing hepatic antioxidant status. Food and Chemical Toxicology. 2007;45:2267-2272
  63. 63. Krishnakantha TP, Lokesh BR. Scavenging of superoxide anions by spice principles. Indian Journal of Biochemistry & Biophysics. 1993;30:133-134
  64. 64. Cao ZF, Chen ZG, Guo P, Zhang SM, Lian LX, Luo L, et al. Scavenging effects of ginger on superoxide anion and hydroxyl radical. Chung Kuo Chung Yao Tsa Chih. 1993;8:750-764
  65. 65. Stoilova I, Krastanov A, Stoyanova A, Denev P, Gargova S. Antioxidant activity of a ginger extract (Zingiber officinale). Food Chemistry. 2007;102(3):764-770
  66. 66. Sueishi Y, Masamoto H, Kotake Y. Heat treatments of ginger root modify but not diminish its antioxidant activity as measured with multiple free radical scavenging (MULTIS) method. Journal of Clinical Biochemistry and Nutrition. 2019;64(2):143-147
  67. 67. Greenwell M, Rahman PKSM. Medicinal plants: Their use in anticancer treatment. International Journal of Pharmaceutical Sciences and Research. 2015;6(10):4103-4112. DOI: 10.13040/IJPSR.0975-8232.6(10).4103-12
  68. 68. Vemuri SK, Banala RR, Subbaiah GPV, Srivastava SK, Reddy AG, Malarvili T. Anti-cancer potential of a mix of natural extracts of turmeric, ginger and garlic: A cell-based study. Egyptian Journal of Basic and Applied Sciences. 2017;4(4):332-344
  69. 69. Ghasemian M, Owlia S, Owlia MB. Review of anti-inflammatory herbal medicines. Advances in Pharmacological Sciences. 2016;2016:9130979. DOI: 10.1155/2016/9130979
  70. 70. Rani PM, Padmakumari KP, Sankarikutty B, Lijo Cherian O, Nisha VM, Raghu KG. Inhibitory potential of ginger extracts against enzymes linked to type 2 diabetes, inflammation and induced oxidative stress. International Journal of Food Sciences and Nutrition. 2011;62(2):106-110
  71. 71. Parmar I, Rupasinghe HPV. Antioxidant capacity and anti-diabetic activity of wild berry stem infusions. European Journal of Medicinal Plants. 2015;8:11-28
  72. 72. Balogun FO, Ashafa AOT. A review of plants in South African traditional medicine used in the prevention and management of hypertension. Planta Medica. 2019;85:312-334
  73. 73. Aming SN. The effect of twice a day intake of ginger tea on the blood pressure of hypertensive individuals in Barangay La Victoria, Aurora, Zamboanga Del Sur. Herdin Record #: R09-ZCHRD-12043023205433. 2006 (abstract)
  74. 74. Kuppusamy P, David RS, Raj P, Ilavenil S, Kaleeswaran B, Govindan N, et al. Evaluation of antihypercholesterolemic effect usingMemecylon eduleRoxb. ethanolic extract in cholesterol-induced Swiss albino mice. Journal of Acute Medicine. 2015;5:85-e91
  75. 75. Iffiu-Soltesz Z, Wanecq E, Lomba A, Portilio MP, Pellati F, Szoto E. Chronic benzylamine administration in the drinking water improves glucose tolerance, reduces body weight gain and circulating cholesterol in high-fat diet-fed mice. Pharmacological Research. 2010;61:355-363
  76. 76. Huseini HF, Kianbakht S, Hajiaghaee R, Dabaghian FH. Antihyperglycemic and anti-hypercholesterolemic effects ofAloe veraleaf gel in hyperlipidemic type 2 diabetic patients: a randomized double-blind placebo-controlled clinical trial. Planta Medica. 2012;78:311-316
  77. 77. Balogun FO, Ashafa AOT. Aqueous roots extract ofDicoma anomala(Sond.) ameliorates isoproterenol –induced myocardial infarction in Wistar rats. Tropical Journal of Pharmaceutical Research. 2016a;15(8):1651-1657
  78. 78. Balogun FO, Ashafa AOT. Protective action of aqueous leaf extract ofGazania krebsiana(Less.) ‘Asteraceae’ antagonizes isoproterenol-triggered myocardial infarction inRattus norvegicus. Comparative Clinical Pathology. 2018;27:461-470
  79. 79. Duke JA. Handbook of Medicinal Herbs. Maryland, USA: CRC Press; 2002
  80. 80. Thomson M, Al-Qattan KK, Al-Sawan SM, Alnaqeeb MA, Khan I, Ali M. The use of ginger (Zingiber officinaleRosc) as a potential antiinflammatory and antithrombotic agent. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 2002;67(6):475-478
  81. 81. Bhandari U, Kanojia R, Pillai KK. Effect of ethanolic extract ofZingiber officinaleon dyslipidaemia in diabetic rats. Journal of Ethnopharmacology. 2005;97(2):227-230
  82. 82. Nammi S, Sreemantula S, Roufogalis BD. Protective effects of ethanolic extract ofZingiber officinalerhizome on the development of metabolic syndrome in high-fat diet-fed rats. Basic & Clinical Pharmacology & Toxicology. 2009;104(5):366-373
  83. 83. Heeba GH, Abd-Elghany MI. Effect of combined administration of ginger (Zingiber officinale) and atorvastatin on the liver of rats. Phytomedicine. 2010;17(14):1076-1081
  84. 84. Elufioye TO, Berida TI, Habtemariam S. Plants-derived neuroprotective agents: Cutting the cycle of cell death through multiple mechanisms. Evidence-based Complementary and Alternative Medicine. 2017;2017:3574012. DOI: 10.1155/2017/3574012
  85. 85. Uddin R, Kim HH, Lee J, Park SU. Neuroprotective effects of medicinal plants. EXCLI Journal. 2013;12:541-545
  86. 86. Shanmugam KR, Mallikarjuna K, Kesireddy N, Sathyavelu RK. Neuroprotective effect of ginger on anti-oxidant enzymes in streptozotocin-induced diabetic rats. Food and Chemical Toxicology. 2011;49:893-897
  87. 87. Sharma P, Singh R. Neuroprotective effect of ginger juice against dichlorvos and lindane induced toxicity in wistar rats. Planta Medica. 2011;77:122
  88. 88. El-Akabawy G, El-Kholy W. Neuroprotective effect of ginger in the brain of streptozotocin-induced diabetic rats. Annals of Anatomy. 2014;196(2-3):119-128
  89. 89. Ha SK, Moon E, Ju MS, Kim DH, Ryu JH, Oh MS, et al. 6-Shogaol, a ginger product, modulates neuroinflammation: A new approach to neuroprotection. Neuropharmacology. 2012;63(2):211-223
  90. 90. Asnaashari S, Dastmalchi S, Javadzadeh Y. Gastroprotective effects of herbal medicines (roots). International Journal of Food Properties. 2018;21(1):902-920
  91. 91. Vutyavanich T, Kraisarin T, Ruangsri RA. Ginger for nausea and vomiting in pregnancy: Randomized, double-masked, placebo-controlled trial. Obstetrics and Gynecology. 2001;97(4):577-582
  92. 92. Bhattarai S, Tran VH, Duke CC. The stability of gingerol and shogaol in aqueous solutions. Journal of Pharmaceutical Sciences. 2001;90(10):1658-1664
  93. 93. Revol B, Gautier-Veyret E, Arrivé C, Fouilhé Sam-Laï N, McLeer-Florin A, Pluchart H, et al. Pharmacokinetic herb-drug interaction between ginger and crizotinib. British Journal of Clinical Pharmacology. 2019:1-2
  94. 94. Abd-Allah GA, El-Bakry KA, Bahnasawy MH, El-Khodary ER. Protective effects of curcumin and ginger on liver cirrhosis induced by carbon tetrachloride in rats. International Journal of Pharmacology. 2016;12:361-369
  95. 95. Balogun FO, Ashafa AOT. Acute and sub-chronic oral toxicity evaluation of aqueous roots extract ofDicoma anomala(Sond.) in Wistar rats. Evidence-based Complementary and Alternative Medicine. 2016b;2016:3509323. DOI: 10.1155/2016/3509323

Written By

Fatai Oladunni Balogun, Esther Tayo AdeyeOluwa and Anofi Omotayo Tom Ashafa

Submitted: June 19th, 2019 Reviewed: July 26th, 2019 Published: September 30th, 2019